Screening and testing in multiples

Clinics in Laboratory Medicine

Volumn 30, Issue 3, 2010, Pages 643-654

  Evans, Mark I ^a,b,c   Andriole, Stephanie ^b  

^a Fetal Medicine Foundation of America   (United States)

^b Comprehensive Genetics ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Multiple pregnancy; Safety; Screening; Testing

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AMNIOCENTESIS; ANEUPLOIDY; CHORION VILLUS SAMPLING; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FERTILIZATION IN VITRO; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HIGH RISK PREGNANCY; HUMAN; INVASIVE PROCEDURE; MATERNAL AGE; MEDICAL DOCUMENTATION; MONOZYGOTIC TWINS; MULTIPLE PREGNANCY; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT COUNSELING; PATIENT IDENTIFICATION; PATIENT SAFETY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURITY; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THERAPEUTIC ABORTION; UNITED STATES; CHROMOSOME ABERRATION; FEMALE; GENETIC COUNSELING; MASS SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTOR;

AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; CHROMOSOME ABERRATIONS; FEMALE; GENETIC COUNSELING; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY REDUCTION, MULTIFETAL; PREGNANCY, MULTIPLE; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 77954807028     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.05.005     Document Type: Review

References (43)

1. Evans MI, Britt DW. Selective reduction in multifetal pregnancies In: Paul M, Grimes D, Stubblefield P. et al, editors. Management of unintended and abnormal pregnancy. London: Blackwell-Wiley; 2009. p. 312-8.
2. Russell R.B., Petrini J.R., Damus K., et al. The changing epidemiology of multiple births in the United States. Obstet Gynecol 2003, 101:129-135.
3. Evans M.I., Yaron Y., Wapner R.J. CVS. Prenatal diagnosis: genetics, reproductive risks, testing, and management 2006, 433-442. McGraw-Hill, New York. M.I. Evans, M.P. Johnson, Y. Yaron (Eds.).
4. Spencer K., Nicolaides K.H. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. BJOG 2003, 110:276-280.
5. Luke B. Monozygotic twinning as a congenital defect and congenital defects in monozygotic twins. Fetal Diagn Ther 1990, 5(2):61-69.
6. Holmes A., Jauniaux E. Prospective study of parental choice for aneuploidy screening in assisted conception versus spontaneously conceived twins. Reprod Biomed Online 2004, 8(2):243-245.
7. Geipel A., Berg C., Katalinic A., et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 2004, 8:119-124.
8. Brambati B., Tului L., Alberti E. Prenatal diagnosis by chorionic villus sampling. Eur J Obstet Gynecol Reprod Biol 1996, 65:11-16.
9. Alfirevic Z., Sundberg K., Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003, 3. CD003252.
10. Alfirevic Z., Tabor A. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007, 109:1203-1204.
11. Mujezinovic F., Alfirevic Z. Procedure related complications of amniocentesis and chorionic villus sampling. Obstet Gynecol 2007, 110:687-694.
12. Yaron Y., Bryant-Greenwood P.K., Dave N., et al. Multifetal pregnancy reductions of triplets to twins: comparison with nonreduced triplets and twins. Am J Obstet Gynecol 1999, 180:1268-1271.
13. Sepulveda W., Sebire N.J., Hughes K., et al. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 1996, 7:421-423.
14. Vayssiere C.F., Heim N., Camus E.P., et al. Determination of chorionicity in twin gestations by high-frequency abdominal ultrasonography: counting the layers of the dividing membrane. Am J Obstet Gynecol 1996, 175:1529-1533.
15. Evans M.I., Galen R.S., Drugan A. Biochemical screening. Prenatal diagnosis: genetics, reproductive risks, testing, and management 2006, 277-288. McGraw-Hill, New York. M.I. Evans, M.P. Johnson, Y. Yaron (Eds.).
16. Wald N.J., Rish S., Hackshaw A.K. Combining nuchal translucency and maternal serum markers in prenatal screening for Down Syndrome in twin pregnancies. Prenat Diagn 2000, 23:588-592.
17. Sebire N.J., Snijders R.J.M., Hughes K., et al. Screening for Trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1996, 103:999-1003.
18. Obrien J.E., Dvorin E., Yaron Y., et al. Differential increases in AFP, hCG, and uE3 in twin pregnancies: impact on attempts to quantify Down Syndrome screening calculations. Am J Med Genet 1997, 73:109-112.
19. Cleary-Goldman J., Berkowitz R.L. First trimester screening for Down Syndrome in multiple pregnancy. Semin Perinatol 2005, 29:395-400.
20. Henry G.P., Britt D.W., Evans M.I. Screening advances and diagnostic choice: the problem of residual risk. Fetal Diagn Ther 2008, 23:308-315.
21. Wald N.J., Rodeck C., Hackshaw A.K., et al. SURUSS in perspective. Br J Obstet Gynaecol 2004, 111:521-531.
22. Gonce A., Borrell A., Fortuny A., et al. First trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?. Prenat Diagn 2005, 25:1156-1161.
23. Evans M.I., Van Decruyes H., Nicolaides K.H. Nuchal translucency (NT) measurements for 1st trimester screening: the ″ price″ of inaccuracy. Fetal Diagn Ther 2007, 22:401-404.
24. Bang J., Nielsen H., Philip J. Prenatal karyotyping of twins by ultrasonically guided amniocentesis. Am J Obstet Gynecol 1975, 123:695-696.
25. Nicolini U., Monni G. Intestinal obstruction in babies exposed in utero to methylene blue. Lancet 1990, 336:1258-1259.
26. Cragan J.D., Martin M.L., Khoury M.J., et al. Dye use during amniocentesis and birth defects. Lancet 1993, 341:1352.
27. Jeanty P., Shah D., Roussis P. Single-needle insertion in twin amniocentesis. J Ultrasound Med 1990, 9:511-517.
28. Machin G.A. Some causes of genotypic and phenotypic discordance in monozygotic twin pairs. Am J Med Genet 1996, 61:216-228.
29. Evans M.I., Rodeck C.H., Johnson M.P., et al. Selective termination in Evans MI. Prenatal diagnosis: genetics, reproductive risks, testing, and management 2006, 571-578. McGraw-Hill, New York. M.P. Johnson, Y. Yaron, A. Drugan (Eds.).
30. Nieuwint A., Zalen-Sprock R., Hummel P., et al. 'Identical' twins with discordant karyotypes. Prenat Diagn 1999, 19:72-76.
31. Evans M.I., Wapner R.J. Invasive prenatal diagnostic procedures 2005. Seminars in perinatology 2005, 29:215-218. Elsevier. U. Reddy, M.T. Mennuti (Eds.).
32. Eddleman K.A., Malone F.D., Sullivan L., et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006, 108(5):1067-1072.
33. Wapner R.J., Evans M.I., Platt L.D. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007, 109:780.
34. Tabor A., Philip J., Madsen M., et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986, 1:1287-1293.
35. De Catte L., Foulon W. Obstetric outcome after fetal reduction to singleton pregnancies. Prenat Diagn 2002, 22:206-210.
36. Evans M.I., Kaufman M., Urban A.J., et al. Fetal reduction from twins to a singleton: a reasonable consideration. Obstet Gynecol 2004, 104:102-109.
37. Wapner R.J., Johnson A., Davis G., et al. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol 1993, 82:49-56.
38. Rhoads G.G., Jackson L.G., Schlesselman S.E., et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989, 320:609-617.
39. Brambati B., Tului L., Guercilena S., et al. Outcome of first-trimester chorionic villus sampling for genetic investigation in multiple pregnancy. Ultrasound Obstet Gynecol 2001, 17:209-216.
40. Caughey A.B., Hopkins L.M., Norton M.E. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006, 108:612-616.
41. Brambati B., Tului L., Baldi M., et al. Genetic analysis prior to selective fetal reduction in multiple pregnancy: technical aspects and clinical outcome. Humanit Rep 1995, 10:818-825.
42. Jenkins T.M., Wapner R.J. The challenge of prenatal diagnosis in twin pregnancies. Curr Opin Obstet Gynecol 2000, 12:87-92.
43. Britt D.W., Evans M.I. Sometimes doing the right thing sucks: frame combinations and multifetal pregnancy reduction decision difficulty. Soc Sci Med 2007, 65:2342-2356.